Mindray marches to marketPACSGEAR moves European office
Varian readies dose calculator
The FDA has cleared a dose calculator for brachytherapy treatment planning. The BrachyVision Acuros product, cleared by the agency for use with Varian Medical Systems’ Eclipse treatment planning system, uses a proprietary method that calculates dose in three to eight minutes. THis compares with the hours it takes using the standard Monte Carlo method. The product, developed by Varian partner Transpire, will be on display July 26 to 30 at the annual meeting of the American Association of Physicists in Medicine in Anaheim, CA.
Mindray marches to market
Mindray Medical International is on track to launch between seven and nine products this year, according to a second-quarter update by the Chinese medical device manufacturer. The company has already released five new products in the first half of 2009. One, the DP-6900, is an upgraded premium portable black-and white ultrasound scanner.
PACSGEAR moves European office
PACS/IT maker PACSGear is relocating its European office to Munich’s high-tech campus, Neue Balan. The company had opened the office elsewhere in Munich less than a year ago. The environmentally friendly green architecture of the Neue Balan campus fits with the firm’s philosophy of eliminating paper from the healthcare process, according to PACSGear.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
A Victory for Radiology: New CMS Proposal Would Provide Coverage of CT Colonography in 2025
July 12th 2024In newly issued proposals addressing changes to coverage for Medicare services in 2025, the Centers for Medicare and Medicaid Services (CMS) announced its intent to provide coverage of computed tomography colonography (CTC) for Medicare beneficiaries in 2025.